|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Antibody Engineering | ||||||||||||||||
| July 18, 2002 | ||||||||||||||||
|
IBC Life Sciences, Paradise Point Resort, San Diego, CA December 1-4, 2002 Antibody Engineering delivers to delegates a detailed source of insights on all aspects of antibody engineering. The symposium reflects the clinical success of monoclonal antibodies over the past several years and the financial success of the immunotherapy sector in the biotechnology marketplace. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | 2002 Antibody Engineering Advisory Board Dr. Richard H.J. Begent, University College London, United Kingdom Dr. Andrew Bradbury, Los Alamos National Laboratory and SISSA, Italy Dr. James B. Breitmeyer, Applied Molecular Evolution Dr. Dennis R. Burton, The Scripps Research Institute Dr. Rathin C. Das, Affitech AS/Affitech USA, Inc. Dr. C. Geoffrey Davis, Abgenix, Inc. Dr. Andrew J.T. George, Imperial College, Hammersmith Hospital, United Kingdom Dr. James S. Huston, EMD-Lexigen Research Center Dr. James Marks, University of California, San Francisco Dr. Andreas Pluckthun, University of Zurich, Switzerland Dr. Ian Tomlinson, Domantis Limited, United Kingdom |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Phone (508) 616-5550 Fax (508) 616-5522 E-mail reg@ibcusa.com Online www.LifeSciencesInfo.com/antibodyeng IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195 |
|||||||||||||||
| E-mail: | jprudhomme@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | ntserver.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||